Trial Profile
The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ospemifene (Primary)
- Indications Menopause
- Focus Pharmacodynamics
- Acronyms Osphena
- 02 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrial.gov record.
- 22 Dec 2013 New trial record